D. E. Shaw & Co »

Upstream Bio shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $736k 27k 27.15

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Palantir Technologies Cl A Call Option (PLTR)
Tesla Motors (TSLA)
Advanced Micro Devices Put Option (AMD)
Apple Put Option (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology Put Option (MU)
Booking Holdings (BKNG)
Meta Platforms Cl A Call Option (META)
Netflix Put Option (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Texas Instruments Incorporated Call Option (TXN)

View all positions for D. E. Shaw & Co

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
BlackRock
Decheng Capital
Norges Bank Investment Management
Enavate Sciences GP
Vanguard Group
UBS Group
Altshuler Shaham
Bain Capital Life Sciences Investors
Omega Fund Management
State Street Corporation
VR Adviser
Wellington Management Company
Geode Capital Management

View all funds holding Upstream Bio